UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Celltrion’s anticancer biosimilar as effective, safe as original drug
Herzuma, Celltrion’s antibody biosimilar used to treat breast and gastric c...
by Marian Chu
|
2017-06-05 15:49
라인
Sewon Cellontech’s cartilage-restoring therapy wins Canadian patent
Sewon Cellontech세원셀론텍’s manufacturing technology of CartiZol (collagen-base...
by Constance Williams
|
2017-05-31 11:05
라인
Macrogen, KAHP to build disease-predicting big data
Macrogen, a precision medical biotechnology company, and the Korea Associat...
by Constance Williams
|
2017-05-26 16:14
라인
Patent war looming over genome editing tech
The recent U.S. ruling regarding the patent dispute over the original techn...
by Nam Doo-hyun
|
2017-05-25 14:12
라인
Medipost wins UK patent for stem-cell treatment of Alzheimer’s
Medipost (CEO Yang Yoon-sun양윤선) has obtained a patent in the United Kingdom...
by Marian Chu
|
2017-05-18 15:01
라인
Government’s bio investment focuses on new drugs
The government has funneled about 10 percent of its fiscal spending on the ...
by Nam Doo-hyun
|
2017-05-12 13:55
라인
WHO official identifies medical barriers in low-income countries
The top 10 diseases have shifted from communicable to non-communicable sick...
by Constance Williams
|
2017-04-28 10:20
라인
SillaJen to receive $4 million milestone thanks to ‘Pexa-Vec’
SillaJen신라젠, a Korean developer of bio drug, said Monday the first European...
by Constance Williams
|
2017-04-26 10:10
라인
Experts identify key trends in biosimilar market growth
Biosimilars have the potential to rake in $60 billion of revenue throughout...
by Marian Chu
|
2017-04-13 11:36
라인
BIO KOREA 2017 touches on ‘three innovations’ in healthcare
BIO KOREA 2017 opened for a three-day run at Coex, Seoul, Wednesday, during...
by Marian Chu
|
2017-04-12 18:18
라인
Insilico enters Korea to focus on skincare, wound-healing
Insilico Medicine, a big data analytics company that applies deep learning ...
by Marian Chu
|
2017-04-12 09:53
라인
Biomedicine boom sweeps domestic drugmakers
A boom to develop biomedicines is sweeping the domestic pharmaceutical comp...
by Lee Hye-seon
|
2017-04-05 18:32
라인
Sale of Remsima rises amid prescription growth in US, Europe
The sales of Remsima (Infliximab), Celltrion’s biosimilar for rheumatoid ar...
by Nam Doo-hyun
|
2017-03-30 15:43
라인
Korean firm to transfer biosimilar tech to Chinese partner
Alteogen, a Korean developer of biosimilars, said Wednesday it would transf...
by Constance Williams
|
2017-03-29 18:04
라인
GemVax & KAEL make bids to develop cure for Alzheimer’s disease
GemVax & KAEL said Thursday that it had signed a contract with Vetter Pharm...
by Constance Williams
|
2017-03-09 11:13
라인
Anam Hospital researchers develop world's first fat stem cell sheet
A team of researchers at Korea University Anam Hospital has developed fat s...
by Constance Williams
|
2017-03-07 16:00
라인
Expert laments three 'nos' in drug industry
Practically every pharmaceutical company CEO outlines his or her aspiration...
by Nam Doo-hyun
|
2017-03-03 11:32
라인
Discovering therapeutic agent for unidentified inflammatory disease
A local research team has discovered a customized drug therapy to determine...
by Constance Williams
|
2017-03-03 10:22
라인
Tie-up with Johnson & Johnson to promote biotech startups
The Korea Health Industry Development Institute (KHIDI) agreed with Johnson...
by Constance Williams
|
2017-02-28 17:08
라인
Can Hongneung area be reborn as 'bio cluster'?
A biomedical industrial complex will open in Hongneung, northern Seoul, in ...
by Nam Doo-hyun
|
2017-02-27 17:08
-
이전
31
32
33
34
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top